Viatris Inc. Common Stock (VTRS) is a publicly traded Healthcare sector company. As of October 3, 2026, VTRS trades at $17.62 with a market cap of $20.05B and a P/E ratio of -48.93. VTRS moved +0.86% today. Year to date, VTRS is +41.25%; over the trailing twelve months it is +74.09%. Its 52-week range spans $6.85 to $18.43. Analyst consensus is buy with an average price target of $19.44. Rallies surfaces VTRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for VTRS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $17.62 |
| Market Cap | $20.05B |
| P/E Ratio | -48.93 |
| EPS | $-0.36 |
| Dividend Yield | 0.12% |
| 52-Week High | $18.43 |
| 52-Week Low | $6.85 |
| Volume | 6.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $14.74B |
| Net Income | $-410.70M |
| Gross Margin | 34.83% |
9 analysts cover VTRS: 0 strong buy, 5 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.44.